The global non-small cell lung carcinoma market is poised for significant expansion over the next decade, according to new industry projections. Valued at USD 8.25 billion in 2023, the NSCLC market is expected to surge to an impressive USD 21.40 billion by 2033, registering a strong compound annual growth rate (CAGR) of 10% during the …
Monthly Archives: April 2025
Global Primary Sclerosing Cholangitis (PSC) Market Set to Soar to USD 314.26 Million by 2033 | FMI
The global primary sclerosing cholangitis (PSC) market is on an impressive growth trajectory, with forecasts estimating a market valuation of USD 314.26 million by 2033. This robust expansion is driven by a significant compound annual growth rate (CAGR) of 7.6% from 2023 to 2033, reflecting a growing commitment to addressing liver diseases and the impact …
Global Amyotrophic Lateral Sclerosis Market Set to Witness Remarkable Growth to Reach USD 1332.22 Million by 2033
The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights (FMI), the market is valued at USD 743.90 million in 2023 and is forecasted to reach an impressive USD 1,332.22 million by 2033, growing at a robust compound …
Global Food Allergy Market Set to Reach USD 66.15 Billion by 2033, Driven by Rising Awareness and Advancements in Treatment Solutions | FMI
The global food allergy market is experiencing remarkable growth, projected to reach a valuation of USD 66.15 Billion by the end of 2033, expanding at a CAGR of 5.2% from its estimated value of USD 39.83 Billion in 2023. This sustained growth is fueled by increasing prevalence of food allergies among children and adults, regulatory …
Global Non-Small Cell Lung Cancer Market to Reach USD 20 Billion by 2033 | FMI
The global non-small cell lung cancer market is on track for exceptional growth, driven by increasing demand for innovative treatment solutions. According to recent market projections, the market value is anticipated to rise from USD 10 billion in 2023 to a staggering USD 20 billion by 2033, achieving a robust Compound Annual Growth Rate (CAGR) …
Continue reading “Global Non-Small Cell Lung Cancer Market to Reach USD 20 Billion by 2033 | FMI”
Global Checkpoint Inhibitor Refractory Cancer Market is expected to reach USD 112.43 Billion by 2033 | FMI Report
The global checkpoint inhibitor refractory cancer market is experiencing significant growth, with an expected valuation of USD 38.69 billion in 2023. This expansion is fueled by the rising health concerns among the global population regarding the increasing prevalence of cancer and the extended indications of existing immunotherapies. Projections indicate that the market will grow at …
Vessel-Sealing Devices Market to Witness Steady Growth from 2025 to 2035, Driven by Technological Advancements and Increasing Demand for Minimally Invasive Surgeries | FMI
The global vessel-sealing devices market is poised for significant expansion from 2025 to 2035, with the increasing prevalence of minimally invasive surgeries, rising global surgical procedure volumes, and rapid advancements in energy-based sealing technologies. The market, valued at USD 1,955.5 million in 2025, is anticipated to reach USD 4,462.3 million by 2035, reflecting a robust …
Global CRBSI Treatment Market to Experience Significant Growth to reach USD 2,908 Million by 2035
The global CRBSI treatment market is on a significant growth trajectory, projected to experience a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. This growth is being propelled by multiple factors, including the rising burden of hospital-acquired infections (HAIs), increased use of central venous catheters (CVC), and continual advancements in antimicrobial therapies. …
Global Bullous Keratopathy Market Poised for Growth, Expected to Reach USD 650 Million by 2033
The global bullous keratopathy market is forecasted to grow at a compounded annual growth rate (CAGR) of 4.3% from 2023 to 2033, is anticipated, with an anticipated closing value of USD 650 Million by 2033. With a valuation of USD 427.54 Million in 2023, as per a new report from Future Market Insights (FMI). The …
Global Swine Vaccines Market Poised for Significant Growth Driven by Rising Demand for Animal Protein, Vaccine Innovation, and Increased Disease Prevalence | FMI
The global swine vaccines market, valued at USD 1.6 billion in 2022, is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.8%. This remarkable growth can be attributed to the increasing demand for animal protein, heightened research and development (R&D) investments for vaccine innovation, and rising …